David A. Wagner

17.0k citations

72 papers · 14.9k indexed · 3 hit papers · h-index 35

Impact in

Biochemistry top 0.1%
- Eicosanoids and Hypertension Pharmacology
- Phytochemicals and Antioxidant Activities
Physiology top 0.2%
- Nitric Oxide and Endothelin Effects

Papers in

Clinical Biochemistry 9
- Metabolism and Genetic Disorders 9
Biochemistry 7

Co-authors: Steven R. Tannenbaum John S. Wishnok Paul L. Skipper Laura C. Green V. R. Young Cynthia Czajkowski S R Tannenbaum John F. Burke
Journals: Molecular Pharmacology (7 papers)Gastroenterology (4 papers)American Journal of Physiology-Endocrinology and Metabolism (4 papers)Proceedings of the National Academy of Sciences (3 papers)Alimentary Pharmacology & Therapeutics (3 papers)
Partner nations: United States Italy Canada

In The Last Decade

David A. Wagner

71 papers receiving 14.3k citations

Hit Papers

align trajectories log scale

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans 2019 · 280 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Science Translational Medicine
1982 Analytical Biochemistry
1981 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by David A. Wagner

Since Specialization

Citations

This map shows the geographic impact of David A. Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Wagner more than expected).

Fields of papers citing papers by David A. Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Wagner. The network helps show where David A. Wagner may publish in the future.

Co-authors

The 25 scholars most cited alongside David A. Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David A. Wagner Line = papers co-authored together David A. Wagner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study Nature Metabolism ·Marja Puurunen, Jerry Vockley, 朱晓林, Stephanie Sacharow, John A. Phillips, William S. Denney, Benjamin D. Goodlett, David A. Wagner, Larry Blankstein, Mary Joan Castillo, Mark R. Charbonneau, Vincent M. Isabella, Zhang Peibi, Richard J. Riese, Caroline Kurtz, Aoife M. Brennan	2021	105
2	Colonic Fermentation and Acetate Production in Youth with and without Obesity Journal of Nutrition ·JOANNA PINTO QUEIROZ DE CARVALHO, Gary W. Cline, Michelle Van Name, Veronika Shabanova, David A. Wagner, C. Lawrence Kien, Nicola Santoro	2021	6
3	An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans Science Translational Medicine ·Caroline Kurtz, Yves Millet, Marja Puurunen, Mylène Perreault, Mark R. Charbonneau, Vincent M. Isabella, Jonathan W. Kotula, Oliver B Patton, Yossi Dagon, William S. Denney, David A. Wagner, Kip A. West, Herbert Feis, Aoife M. Brennan, Paul Miller Hit paper breakdown →	2019	280
4	Role of Gut Microbiota and Short Chain Fatty Acids in Modulating Energy Harvest and Fat Partitioning in Youth The Journal of Clinical Endocrinology & Metabolism ·Martina Goffredo, Frederick P. Drowne, Elizabeth J. Parks, David A. Wagner, Kristof J Nordin, Joerg Graf, Mary Savoye, Bridget Pierpont, Gary W. Cline, Nicola Santoro	2016	128
5	Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis American Journal of Clinical Nutrition ·Joseph Lee, Jennifer E. Lambert, Janet P. Sacriz, María A. Ramos-Román, Justin R. Trombold, David A. Wagner, Elizabeth J. Parks	2014	125
6	Antispila oinophylla new species (Lepidoptera, Heliozelidae), a new North American grapevine leafminer invading Italian vineyards: taxonomy, DNA barcodes and life cycle ZooKeys ·E.J. van Nieukerken, David A. Wagner, M. Baldessari, Luca Mazzon, G. Angeli, V. Girolami, Carlo Duso, Camiel Doorenweerd	2012	35
7	Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial Hepatology ·Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, Timothy R. Morgan, Richard K. Sterling, David A. Wagner, احمد الدخيل, Teresa M. Curto, Anne Stoddard, Elizabeth C. Wright	2011	52
8	A State-Dependent Salt-Bridge Interaction Exists across the β/α Intersubunit Interface of the GABAA Receptor Molecular Pharmacology ·Alessandra Zamunaro, David A. Wagner	2011	18
9	A super-agonist of growth hormone–releasing hormone causes rapid improvement of nutritional status in patients with chronic kidney disease Kidney International ·Stanisław Niemczyk, Hanna Sikorska, Andrzej Więcek, E Zukowska-Szczechowska, Vitalii Grinenko, 边纪, Zihao Yang, Aneta Formánková, 山下純宏, Johannes D. Veldhuis, David A. Wagner, Pierrette Gaudreau, Tiina Hakonen, P Delore, Taneli Jouhikainen, Franz Schaefer	2009	17
10	Quantifying Gastric Helicobacter pylori Infection: A Comparison of Quantitative Culture, Urease Breath Testing, and Histology Digestive Diseases and Sciences ·Sanjeev Tummala, Sunil G. Sheth, Jeffrey D. Goldsmith, Sarah Sell, Christopher K. Murphy, Marcia S. Osburne, احمد برهان عبد الرحمن, Welsh P, David A. Wagner, Ciarán P. Kelly	2007	12
11	Kinetics and Spontaneous Open Probability Conferred by the ϵ Subunit of the GABA_AReceptor Journal of Neuroscience ·David A. Wagner, Marcel P Goldschen-Ohm, Tim G. Hales, Mathew V. Jones	2005	38
12	Effect of Triglyceride Structure on Fecal Excretion of ¹³ C-Labeled Triglycerides Journal of the American College of Nutrition ·Sally A. Schuette, Morteza Janghorbani, Mitchell B. Cohen, Viсtor Ivanovich Lesnyak, Zehra Dökmen, David A. Wagner, Eugene P. DiMagno	2003	3
13	Dysprosium Chloride as a Nonabsorbable Gastrointestinal Marker for Studies of Stable Isotope-Labeled Triglyceride Excretion in Man Journal of the American College of Nutrition ·Sally A. Schuette, Morteza Janghorbani, Mitchell B. Cohen, Viсtor Ivanovich Lesnyak, Zehra Dökmen, David A. Wagner, Steven J. Morris	2003	8
14	Setuid Demystified USENIX Security Symposium ·Hao Chen, David A. Wagner, Drew Dean	2002	50
15	Protein mobility and GABA-induced conformational changes in GABAA receptor pore-lining M2 segment Nature Neuroscience ·Jeffrey Horenstein, David A. Wagner, Cynthia Czajkowski, Myles H. Akabas	2001	135
16	Protein kinase C potentiation of currents from mouse ζ1/ε2 NMDA receptors expressed in Xenopus oocytes depends on f-actin/g-actin cycling Neuroscience Letters ·David A. Wagner, John P. Leonard	1999	9
17	Determination of the isotope enrichment of one or a mixture of two stable labelled tracers of the same compound using the complete isotopomer distribution of an ion fragment; theory and application toin vivo human tracer studies Journal of Mass Spectrometry ·Seung-Ok Yoo, T. E. Chapman, David A. Wagner, Vernon R. Young, John F. Burke	1993	36
18	Performance of Human Mass Balance/Metabolite Identification Studies Using Stable Isotope (¹³C, ¹⁵N) Labeling and Continuous‐Flow Isotope‐Ratio Mass Spectrometry as an Alternative to Radioactive Labeling Methods The Journal of Clinical Pharmacology ·Thomas R. Browne, George Szabó, Alfred Ajami, David A. Wagner	1993	14
19	Prolonged fasting as conditioned by prior protein depletion: Effect on urinary nitrogen excretion and whole-body protein turnover Metabolism ·François Larivière, David A. Wagner, José Jhaiver Anzola Peraza, L. John Hoffer	1990	6
20	Plasma proline kinetics and the regulation of proline synthesis in man Metabolism ·Tom Jaksic, David A. Wagner, John F. Burke, Ф Ю Попеленский	1987	31

About David A. Wagner

David A. Wagner is a scholar working on Clinical Biochemistry, Biochemistry, Gastroenterology, Cellular and Molecular Neuroscience and Physiology, having authored 72 papers that have together received 14.9k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (15 papers), Diet and metabolism studies (13 papers), Ion channel regulation and function (10 papers), Metabolism and Genetic Disorders (9 papers), Receptor Mechanisms and Signaling (9 papers), Muscle metabolism and nutrition (7 papers), Nicotinic Acetylcholine Receptors Study (7 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Biochemistry (1.3k citations), Physiology (4.1k citations), Pharmacology (911 citations), Biological Psychiatry (259 citations) and Complementary and alternative medicine (843 citations). David A. Wagner has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Steven R. Tannenbaum, John S. Wishnok, Paul L. Skipper, Laura C. Green, V. R. Young, Cynthia Czajkowski, S R Tannenbaum, John F. Burke, Nawfal W. Istfan and William Rand. Their work appears in journals such as Molecular Pharmacology, Gastroenterology, American Journal of Physiology-Endocrinology and Metabolism, Proceedings of the National Academy of Sciences and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact